TREATMENT-RELATED ACUTE MYELOID LEUKEMIA
Clinical trials for TREATMENT-RELATED ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new TREATMENT-RELATED ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for TREATMENT-RELATED ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers: venetoclax combo enters human trials
Disease control Recruiting nowThis early-phase trial is testing whether adding the drug venetoclax to standard chemotherapy is safe and tolerable for children, adolescents, and young adults with high-risk blood cancers like MDS, AML, and ALL. About 30 participants will receive different combinations of chemot…
Matched conditions: TREATMENT-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Andrew E. Place, MD • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for young AML patients: drug cocktail targets resistant cancer
Disease control Recruiting nowThis early-phase trial is testing whether adding the drug venetoclax to a standard chemotherapy regimen can help children and young adults whose acute myeloid leukemia (AML) has come back or not responded to treatment. About 40 participants will receive different doses of venetoc…
Matched conditions: TREATMENT-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC